NCT02703051View on ClinicalTrials.gov

A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

GMI-1271

DRUG

Filgrastim

DRUG

Placebo Injection

DRUG

Placebo Infusion

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

GlycoMimetics Incorporated

INDUSTRY